Review article · 2024
Engineered immune cells as therapeutics for autoimmune diseases
Trends in biotechnology, 42(7), 842–858 · Published 16 February 2024 · DOI 10.1016/j.tibtech.2024.01.006
In brief
“Engineered immune cells as therapeutics for autoimmune diseases” is a 2024 review article by Moncef Zouali, published in Trends in biotechnology. OpenAlex counts 15 citations as of 20 November 2026, which puts it in the top 7% of works published in 2024 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 15
- Most cited in
- 2026 (7)
- Field-weighted impact
- 0.72
- References
- 92
- Authors
- 1
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zouali, M. (2024). Engineered immune cells as therapeutics for autoimmune diseases. Trends in biotechnology, 42(7), 842–858. https://doi.org/10.1016/j.tibtech.2024.01.006
MLA 9
Zouali, Moncef. “Engineered immune cells as therapeutics for autoimmune diseases.” Trends in biotechnology, vol. 42, no. 7, 2024, pp. 842–858. https://doi.org/10.1016/j.tibtech.2024.01.006.
Chicago
Zouali, Moncef. 2024. “Engineered immune cells as therapeutics for autoimmune diseases.” Trends in biotechnology 42 (7): 842–858. https://doi.org/10.1016/j.tibtech.2024.01.006.
Harvard
Zouali, M. (2024) ‘Engineered immune cells as therapeutics for autoimmune diseases’, Trends in biotechnology, 42(7), pp. 842–858. doi:10.1016/j.tibtech.2024.01.006.
IEEE
M. Zouali, “Engineered immune cells as therapeutics for autoimmune diseases,” Trends in biotechnology, vol. 42, no. 7, pp. 842–858, 2024, doi: 10.1016/j.tibtech.2024.01.006.
BibTeX
@article{zouali2024engineered,
title = {{Engineered immune cells as therapeutics for autoimmune diseases}},
author = {Zouali, Moncef},
journal = {Trends in biotechnology},
year = {2024},
volume = {42},
number = {7},
pages = {842--858},
doi = {10.1016/j.tibtech.2024.01.006},
url = {https://doi.org/10.1016/j.tibtech.2024.01.006}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 2 | |
| 2025 | 6 | |
| 2026 | 7 |
Its field-weighted citation impact is 0.72: it has been cited 0.72 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- engineered immune cells
- autoimmune disease
- B-cell depletion
- B cells
- biologic therapy
- immunosuppressive therapy
- B cell-targeted therapy
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Zouali, M. (2024). Engineered immune cells as therapeutics for autoimmune diseases. Trends in biotechnology, 42(7), 842–858. https://doi.org/10.1016/j.tibtech.2024.01.006
How many times has this paper been cited?
15 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Moncef Zouali.
What is the DOI of this paper?
10.1016/j.tibtech.2024.01.006, permanently at https://doi.org/10.1016/j.tibtech.2024.01.006. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.